Every week Australians wheel their yellow recycling bins to the curb. But as more and more countries refuse to deal with our "contaminated" plastics, it's clear we need to rethink our approach.
If Novo Nordisk is to fulfil the potential of its anti-obesity drug Saxenda, it needs more doctors to have a new understanding of how obesity really works. And to prescribe. Again and again.
While our current religious discrimination laws vary from state to state, and are at times contradictory, would having a consistent religious discrimination act be a good thing?
The race to find a pharmacological way to combat obesity is on — and in addition to financial pressures, it has proven devilishly difficult to make an obesity drug that is effective, safe and works at scale, across a population.
Getting doctors and medical bodies to classify obesity as a 'disease' would be a huge win for pharmaceutical companies. Here's how they're trying to do just that.
What would selling Australian curriculum like the HSC and VCE mean for our economy, and is it viable? We've done our homework.
INQ visits a modern seminary, historically obscured from public view, and speaks to priests in training — as well as to some who opted out — to find out about the changing reality and day-to-day lives of those on the path to priesthood.